Warning: The NCBI web site requires JavaScript to function. more...
Role of interleukin-7 in degenerative and inflammatory joint diseases.
van Roon JA, Lafeber FP.
Arthritis Res Ther. 2008;10(2):107. Epub 2008 Apr 18.
Related citations
Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP.
Arthritis Rheum. 2009 Sep;60(9):2595-605.
The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
Jacques C, Gosset M, Berenbaum F, Gabay C.
Vitam Horm. 2006;74:371-403. Review.
Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S, Joosten LA, Helsen MM, Walgreen B, van Lent PL, van den Bersselaar LA, Koenders MI, van den Berg WB.
Arthritis Rheum. 2008 Dec;58(12):3753-64.
Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC, van Lent PL, Koenders MI, Walgreen B, Sloetjes AW, Nimmerjahn F, Sjef Verbeek J, van den Berg WB.
Arthritis Rheum. 2009 Feb;60(2):396-407.
Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.
Andreas K, Häupl T, Lübke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C.
Arthritis Res Ther. 2009;11(1):R15. Epub 2009 Feb 3.
[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].
Jouzeau JY, Moulin D, Koufany M, Sebillaud S, Bianchi A, Netter P.
J Soc Biol. 2008;202(4):289-312. Epub 2008 Dec 19. Review. French.
Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL, Grevers LC, Blom AB, Arntz OJ, van de Loo FA, van der Kraan P, Abdollahi-Roodsaz S, Srikrishna G, Freeze H, Sloetjes A, Nacken W, Vogl T, Roth J, van den Berg WB.
Arthritis Rheum. 2008 Dec;58(12):3776-87.
Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.
Shakibaei M, Csaki C, Nebrich S, Mobasheri A.
Biochem Pharmacol. 2008 Dec 1;76(11):1426-39. Epub 2008 Jun 3.
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.
Moran EM, Mullan R, McCormick J, Connolly M, Sullivan O, Fitzgerald O, Bresnihan B, Veale DJ, Fearon U.
Arthritis Res Ther. 2009;11(4):R113. Epub 2009 Jul 23.
Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL, Hofkens W, Blom AB, Grevers L, Sloetjes A, Takahashi N, van Tits LJ, Vogl T, Roth J, de Winther MP, van den Berg WB.
Arthritis Rheum. 2009 Oct;60(10):2954-65.
A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes.
Klatt AR, Paul-Klausch B, Klinger G, Kühn G, Renno JH, Banerjee M, Malchau G, Wielckens K.
J Orthop Res. 2009 Jan;27(1):65-70.
Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y, Lee JH, DiMicco MA, Vanderploeg EJ, Blake SM, Hung HH, Plaas AH, James IE, Song XY, Lark MW, Grodzinsky AJ.
Arthritis Rheum. 2009 Oct;60(10):2985-96.
Biologics in development for rheumatoid arthritis: relevance to osteoarthritis.
Abramson SB, Yazici Y.
Adv Drug Deliv Rev. 2006 May 20;58(2):212-25. Epub 2006 Feb 28. Review.
Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
Furuzawa-Carballeda J, Macip-Rodríguez PM, Cabral AR.
Clin Exp Rheumatol. 2008 Jul-Aug;26(4):554-60.
Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, Pillinger MH, Abramson SB.
J Immunol. 2008 Oct 1;181(7):5082-8. Erratum in: J Immunol. 2009 Jul 15;183(2):1496.
Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.
Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lavigne M, Martel-Pelletier J.
Arthritis Res Ther. 2009;11(4):R119. Epub 2009 Aug 7.
Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
Clutterbuck AL, Mobasheri A, Shakibaei M, Allaway D, Harris P.
Ann N Y Acad Sci. 2009 Aug;1171:428-35.
Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism.
Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, Galera P, Boumediene K.
Connect Tissue Res. 2008;49(3):293-7. Review.
The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP, Raychaudhuri SK.
Scand J Rheumatol. 2009 May-Jun;38(3):207-15.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on